Abstract:Background
Combined chemotherapy is often affected by the different physicochemical properties of chemotherapeutic drugs, which should be improved by the reasonable design of co-loaded preparations.
Purpose
A kind of simple but practical graphene oxide (GO) wrapped mesoporous silica nanoparticles (MSN) modified with hyaluronic acid (MSN@GO-HA) were developed for the co-delivery of cinnamaldehyde (CA) and doxorubicin (DOX), in order to enhance their combined treatment on… Show more
“…Zhao et al suggested that CA encapsulated in submicrometer emulsions exhibited higher plasma concentration, faster tissue distribution, and better antitumor effects in rats when compared to CA alone [ 32 ]. Similarly, Dong et al reported that nanogel packaging of CA enabled the controlled release and oxidation inhibition of drug and oxidation inhibition, which consequently increased CA's bioavailability and more effectively promoted cancer cell apoptosis [ 53 ]. With the advancement in molecular biology, a large number of bioactive substances, including dextran, silica, chitosan, cyclodextrin, and hyaluronic acid, have been found to synthesize carriers for improving the therapeutic efficacy of CA [ 46 , 48 , 51 , 53 , 60 ].…”
Section: Progress In the Pharmacological Characteristics Of Camentioning
Evidence from epidemiological studies has demonstrated that the incidence and mortality of cardiovascular diseases (CVDs) increase year by year, which pose a great threat on social economy and human health worldwide. Due to limited therapeutic benefits and associated adverse effects of current medications, there is an urgent need to uncover novel agents with favorable safety and efficacy. Cinnamaldehyde (CA) is a bioactive phytochemical isolated from the stem bark of Chinese herbal medicine Cinnamon and has been suggested to possess curative roles against the development of CVDs. This integrated review intends to summarize the physicochemical and pharmacokinetic features of CA and discuss the recent advances in underlying mechanisms and potential targets responsible for anti-CVD properties of CA. The CA-related cardiovascular protective mechanisms could be attributed to the inhibition of inflammation and oxidative stress, improvement of lipid and glucose metabolism, regulation of cell proliferation and apoptosis, suppression of cardiac fibrosis, and platelet aggregation and promotion of vasodilation and angiogenesis. Furthermore, CA is likely to inhibit CVD progression via affecting other possible processes including autophagy and ER stress regulation, gut microbiota and immune homeostasis, ion metabolism, ncRNA expression, and TRPA1 activation. Collectively, experiments reported previously highlight the therapeutic effects of CA and clinical trials are advocated to offer scientific basis for the compound future applied in clinical practice for CVD prophylaxis and treatment.
“…Zhao et al suggested that CA encapsulated in submicrometer emulsions exhibited higher plasma concentration, faster tissue distribution, and better antitumor effects in rats when compared to CA alone [ 32 ]. Similarly, Dong et al reported that nanogel packaging of CA enabled the controlled release and oxidation inhibition of drug and oxidation inhibition, which consequently increased CA's bioavailability and more effectively promoted cancer cell apoptosis [ 53 ]. With the advancement in molecular biology, a large number of bioactive substances, including dextran, silica, chitosan, cyclodextrin, and hyaluronic acid, have been found to synthesize carriers for improving the therapeutic efficacy of CA [ 46 , 48 , 51 , 53 , 60 ].…”
Section: Progress In the Pharmacological Characteristics Of Camentioning
Evidence from epidemiological studies has demonstrated that the incidence and mortality of cardiovascular diseases (CVDs) increase year by year, which pose a great threat on social economy and human health worldwide. Due to limited therapeutic benefits and associated adverse effects of current medications, there is an urgent need to uncover novel agents with favorable safety and efficacy. Cinnamaldehyde (CA) is a bioactive phytochemical isolated from the stem bark of Chinese herbal medicine Cinnamon and has been suggested to possess curative roles against the development of CVDs. This integrated review intends to summarize the physicochemical and pharmacokinetic features of CA and discuss the recent advances in underlying mechanisms and potential targets responsible for anti-CVD properties of CA. The CA-related cardiovascular protective mechanisms could be attributed to the inhibition of inflammation and oxidative stress, improvement of lipid and glucose metabolism, regulation of cell proliferation and apoptosis, suppression of cardiac fibrosis, and platelet aggregation and promotion of vasodilation and angiogenesis. Furthermore, CA is likely to inhibit CVD progression via affecting other possible processes including autophagy and ER stress regulation, gut microbiota and immune homeostasis, ion metabolism, ncRNA expression, and TRPA1 activation. Collectively, experiments reported previously highlight the therapeutic effects of CA and clinical trials are advocated to offer scientific basis for the compound future applied in clinical practice for CVD prophylaxis and treatment.
“…Dong et al. ( 2020 ) developed mesoporous silica nanoparticles ( Figure 6 ) coated with graphene oxide modified by HA for the combined administration of CA and DOX to enhance their combined therapeutic effect on tumor cells. CA and DOX co-loaded graphene oxide coated mesoporous silica nanoparticles (MSNCA @ GODOX-HA) actively targeted tumor cells through the “ligand receptor” affinity between HA and CD44 receptors, improved the advantages of CA and DOX, limited their shortcomings, so as to achieve effective treatment of cancer.…”
Section: Types and Characteristics Of Ndcdsmentioning
Chemotherapy drugs have been used for a long time in the treatment of cancer, but serious side effects are caused by the inability of the drug to be solely delivered to the tumor when treating cancer with chemotherapy. Natural products have attracted more and more attention due to the antitumor effect in multiple ways, abundant resources and less side effects. Therefore, the combination of natural active ingredients and chemotherapy drugs may be an effective antitumor strategy, which can inhibit the growth of tumor and multidrug resistance, reduce side effects of chemotherapy drugs. Nano-drug co-delivery system (NDCDS) can play an important role in the combination of natural active ingredients and chemotherapy drugs. This review provides a comprehensive summary of the research status and application prospect of nano-delivery strategies for the combination of natural active ingredients and chemotherapy drugs, aiming to provide a basis for the development of anti-tumor drugs.
“…DOX was employed as the fluorescent probe as it emits red fluorescence under a specified wavelength of excitation light. 41,42 The cell nuclei were stained in blue by DAPI since it is a fluorescent dye that binds strongly to DNA. As shown in Fig.…”
Colorectal cancer (CRC) is the second leading cause of cancer death among all malignancies. Drug delivery targeting tumor surface receptors improves therapeutic effects and lowers side-effects since it can increase...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.